Keralink International Provides $2.5 Million In Seed Funding To Enable Development Of Bioengineered Corneal Implants
Keralink International Provides $2.5 Million In Seed Funding To Enable Development Of Bioengineered Corneal Implants
11/13/23, 8:26 PM
Location
baltimoreMoney raised
$2.5 million
Industry
biotechnology
health care
Round Type
seed
Investors
Kera Link International
KeraLink International (KLI) today announced $2.5 million in seed funding in Pantheon Vision (PV) to launch the development of a novel advancement to help eradicate corneal blindness in both developed and low- and middle-income countries (LMICs).
Company Info
Location
baltimore, maryland, united states
Additional Info
Pantheon Vision is an early-stage biotech company developing bioengineered corneal implants to improve corneal procedures and reduce the reliance on donor tissue to address corneal blindness in emerging and developed markets.